Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn’s Disease Patients Undergoing Ileocolic Resection | Zendy

Ravi S. Shah | Zendy; Salam Bachour | Zendy; Xue Jia | Zendy; Stefan D. Holubar | Zendy; Tracy L. Hull | Zendy; JeanPaul Achkar | Zendy; Jessica Philpott | Zendy; Taha Qazi | Zendy; Florian Rieder | Zendy; Benjamin L. Cohen | Zendy; Miguel Regueiro | Zendy; Amy L. Lightner | Zendy; Benjamin Click | Zendy

Open Access

Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn’s Disease Patients Undergoing Ileocolic Resection

Author(s) -

Ravi S. Shah,

Salam Bachour,

Xue Jia,

Stefan D. Holubar,

Tracy L. Hull,

JeanPaul Achkar,

Jessica Philpott,

Taha Qazi,

Florian Rieder,

Benjamin L. Cohen,

Miguel Regueiro,

Amy L. Lightner,

Benjamin Click

Publication year - 2020

Publication title -

journal of crohn s and colitis

Language(s) - English

Resource type - Journals

eISSN - 1876-4479

pISSN - 1873-9946

DOI - 10.1093/ecco-jcc/jjaa268

Subject(s) - medicine , vedolizumab , crohn's disease , ustekinumab , surgery , complication , abdominal surgery , bowel resection , disease , infliximab

There are limited data on the postoperative outcomes in Crohn's disease patients exposed to preoperative ustekinumab or vedolizumab. We hypothesised that preoperative biologic use in Crohn's disease is not associated with postoperative complications after ileocolic resection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research